INFLAZYME

Serial Number 75302610
602

Registration Progress

Application Filed
Jun 3, 1997
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

INFLAZYME

Basic Information

Serial Number
75302610
Filing Date
June 3, 1997
Abandonment Date
January 18, 2008
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Feb 12, 2008
Classes
005

Rights Holder

INFLAZYME PHARMACEUTICALS LTD

03
Address
Ste. 460, 999 W. Broadway Avenue
Vancouver, British Columbia V5Z 1K5
CA

Ownership History

INFLAZYME PHARMACEUTICALS LTD

Original Applicant
03
Vancouver, British Columbia CA

Legal Representation

Attorney
LAWRENCE A MAXHAM

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

50 events
Date Code Type Description
Feb 12, 2008 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Feb 12, 2008 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jul 17, 2007 CNSI R SUSPENSION INQUIRY WRITTEN
Jul 17, 2007 GNSI S INQUIRY TO SUSPENSION E-MAILED
Jul 17, 2007 GNS2 O NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jan 11, 2007 ALIE A ASSIGNED TO LIE
Jan 11, 2007 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 11, 2007 ACEC I AMENDMENT FROM APPLICANT ENTERED
Jan 11, 2007 CNSL R SUSPENSION LETTER WRITTEN
Jan 11, 2007 GNSL S LETTER OF SUSPENSION E-MAILED
Dec 5, 2006 MAIL I PAPER RECEIVED
Oct 18, 2006 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 7, 2006 CNSI R SUSPENSION INQUIRY WRITTEN
Jun 7, 2006 CNSI S INQUIRY AS TO SUSPENSION MAILED
Feb 9, 2006 DOCK D ASSIGNED TO EXAMINER
Dec 7, 2005 ACEC I AMENDMENT FROM APPLICANT ENTERED
Dec 7, 2005 CNSL R SUSPENSION LETTER WRITTEN
Dec 7, 2005 CNSL S LETTER OF SUSPENSION MAILED
Nov 18, 2005 MAIL I PAPER RECEIVED
Nov 18, 2005 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 2, 2005 CNSI S INQUIRY AS TO SUSPENSION MAILED
Jun 1, 2005 CNSI R SUSPENSION INQUIRY WRITTEN
Dec 1, 2004 CNSL S LETTER OF SUSPENSION MAILED
Nov 30, 2004 ACEC I AMENDMENT FROM APPLICANT ENTERED
Nov 30, 2004 CNSL R SUSPENSION LETTER WRITTEN
Oct 12, 2004 MAIL I PAPER RECEIVED
Oct 12, 2004 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 14, 2004 CNSI S INQUIRY AS TO SUSPENSION MAILED
Sep 24, 2003 CNSL S LETTER OF SUSPENSION MAILED
Sep 8, 2003 CFIT O CASE FILE IN TICRS
Aug 14, 2003 MAIL I PAPER RECEIVED
Aug 14, 2003 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 30, 2003 CNSI S INQUIRY AS TO SUSPENSION MAILED
Aug 13, 2002 CNSL S LETTER OF SUSPENSION MAILED
Jul 17, 2002 MAIL I PAPER RECEIVED
Jul 17, 2002 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2002 CNSI S INQUIRY AS TO SUSPENSION MAILED
Nov 2, 2001 CNSL S LETTER OF SUSPENSION MAILED
Aug 6, 2001 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 12, 2001 CNSI O INQUIRY AS TO SUSPENSION MAILED
Aug 22, 2000 CNSL F LETTER OF SUSPENSION MAILED
Feb 17, 2000 CNSI O INQUIRY AS TO SUSPENSION MAILED
Aug 10, 1999 CNSL F LETTER OF SUSPENSION MAILED
Jul 2, 1999 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 27, 1999 CNSI O INQUIRY AS TO SUSPENSION MAILED
Aug 11, 1998 CNSL F LETTER OF SUSPENSION MAILED
Aug 4, 1998 CNEA F EXAMINER'S AMENDMENT MAILED
Jul 9, 1998 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 9, 1998 CNRT F NON-FINAL ACTION MAILED
Jan 8, 1998 DOCK D ASSIGNED TO EXAMINER

Detailed Classifications

Class 005
pharmaceuticals for treatment of inflammatory diseases; medical diagnostic kits comprised of glass vials, diagnostic reagents and instructions for use in diagnosis of tuberculosis
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Pseudo Mark
INLAZY ME

Classification

International Classes
005

USPTO Documents

Loading USPTO documents...